Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit

A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), caused a worldwide pandemic. Our aim in this study is to produce new fusion inhibitors against SARS-CoV-2, which can be the basis for developing new antiviral drugs. The fusion core comprising the heptad repeat domain...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandeel, Mahmoud, Yamamoto, Mizuki, Tani, Hideki, Kobayashi, Ayako, Gohda, Jin, Kawaguchi, Yasushi, Park, Byoung Kwon, Kwon, Hyung-Joo, Inoue, Jun-ichiro, Alkattan, Abdallah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094075/
https://www.ncbi.nlm.nih.gov/pubmed/33424013
http://dx.doi.org/10.4062/biomolther.2020.201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094075/
https://www.ncbi.nlm.nih.gov/pubmed/33424013
http://dx.doi.org/10.4062/biomolther.2020.201

Ejemplares similares